Table 2.
CC | HFHF | PT15 | PT30 | RSV30 | |
---|---|---|---|---|---|
Lobular inflammation | |||||
None (0) | 10 | 0 | 0 | 2 | 0 |
Mild (1) | 0 | 5 | 8 | 8 | 7 |
Moderate (2) | 0 | 5 | 2 | 0 | 3 |
Ballooning degeneration | |||||
None (0) | 10 | 0 | 0 | 0 | 0 |
Few (1) | 0 | 0 | 0 | 0 | 0 |
Many (2) | 0 | 10 | 10 | 10 | 10 |
Fibrosis | |||||
Stage 0 | 0 | 9 | 10 | 10 | 10 |
Stage 1A | 0 | 1 | 0 | 0 | 0 |
NAS | 0 ± 0 | 5.4 ± 0.4 | 3.8 ± 0.3 | 3.1 ± 0.3 | 3.8 ± 0.3 |
Lobular inflammation was graded according to the number of inflammatory foci per 200 field (0 is no foci; 1 is < 2 foci per 200 × field; 2 is 2–4 foci per 200 × field); hepatocellular ballooning was graded as none (0), few balloon cells (1), and many cells/prominent ballooning (2); fibrosis stage was graded as none (Stage 0) or mild perisinusoidal fibrosis (Stage 1A); NAS: non-alcoholic fatty liver disease score.